One synthetic peptide reaches three receptor systems that each shape appetite, blood glucose and fat metabolism, which is why retatrutide has become one of the most closely watched research compounds in metabolic science
Two weeks ago, the first of the highly anticipated Phase 3 clinical-trial results corroborated the jaw-dropping initial numbers: Patients lost on average 71 pounds, or 29 percent of their body weightdouble what people lose on semaglutide, which is better known as Ozempic or Wegovy
This finding could pave the way for more targeted treatments that go beyond blood sugar management to directly address kidney deterioration and cardiovascular risks in diabetes
Nature 343, 3843
Among individuals who were not optimally controlled and received treatment intensification, mean time to intensification was 4.17 ( 5.24) months in GLP-1RA users, 3.48 ( 5.52) months in the SGLT2i group and 7.62 ( 10.89) months in the insulin group
Managing Ingredient Compatibility Ingredient compatibility is a critical consideration when developing a GLP-1 support supplement